Dental Times

clinical

ProEncia Advances Novel Periodontal Disease Treatments

Fast-growth biopharma startup develops groundbreaking product pipeline to target oral health epidemic. Twin Cities-based ProEncia Biotechnology, a biopharma startup, today announced the company has closed significant pre-seed funding to advance its next-generation periodontal disease treatment. Funding will be applied to further develop, commercialize, and license a pipeline of novel, non-invasive periodontal care products designed for […] The post ProEncia Advances Novel Periodontal Disease Treatments appeared first on Dentistry Today.

By Dentistry Today ·

Fast-growth biopharma startup develops groundbreaking product pipeline to target oral health epidemic. Twin Cities-based ProEncia Biotechnology, a biopharma startup, today announced the company has closed significant pre-seed funding to advance its next-generation periodontal disease treatment. Funding will be applied to further develop, commercialize, and license a pipeline of novel, non-invasive periodontal care products designed for […]

The post ProEncia Advances Novel Periodontal Disease Treatments appeared first on Dentistry Today.

Read the original reporting at Dentistry Today